Why Clearside Biomedical Stock Surged Today

Why Clearside Biomedical Stock Surged Today

As of 3 p.m. EDT, the biopharmaceutical company's stock price was up more than 12% after rising as much as 47% earlier in the day. Clearside Biomedical is developing an experimental treatment for wet age-related macular degeneration (AMD). Investors bid up eye care specialist Clearside Biomedical's shares on Thursday.